SPAC News

Biotechnology
SPAC News

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement

Zurich, Switzerland, and Brooklyn, New York, USA – VERAXA Biotech AG and Voyager Acquisition Corp. (NASDAQ: VACH) have announced a definitive business combination agreement. The proposed combination would result in a publicly traded, clinical-stage biopharmaceutical company, VERAXA Biotech AG, focused on next-generation cancer therapies, and is expected to list on NASDAQ under the ticker symbol “VERX.”

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement Read more »

Health
SPAC News

Aimfinity Investment Corp. I Announces Approval by Shareholders of its Business Combination with Docter Inc.

Wilmington, DE – Aimfinity Investment Corp. I (Nasdaq: AIMA, AIMAU, AIMAW) announced that its business combination with Docter Inc., a Taiwanese health technology company, was approved at an extraordinary general meeting of shareholders on March 27, 2025.

Aimfinity Investment Corp. I Announces Approval by Shareholders of its Business Combination with Docter Inc. Read more »

Scroll to Top